Sign in
Taking peopleNo phase

Minimally Invasive Surgery For Patients With Spontaneous Deep Intracerebral Hemorrhage

Key facts

Who runs it
Huynh Quoc Huy
Where
Vietnam1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
300 people, planned
Started
8 Sept 2025
Expected to end
1 Sept 2028
Type of study
Observational, 2 groups
Record updated
19 November 2025

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 22 criteriaShow less

Who can take part

  • Age 18 to 80 years
  • Spontaneous basal ganglia intracerebral hemorrhage confirmed by non-contrast CT scan
  • Hematoma volume 30-80 mL (ABC/2 method)
  • Time from onset/last known well ≤ 72 hours
  • Glasgow Coma Scale (GCS) score 5-14 at admission
  • Pre-stroke modified Rankin Scale (mRS) score 0-1

Who cannot take part

  • Secondary intracerebral hemorrhage due to trauma, tumor, vascular malformation, aneurysm, or hemorrhagic transformation of ischemic stroke
  • Infratentorial hemorrhage (brainstem or cerebellum)
  • Primary thalamic hemorrhage
  • Extensive intraventricular hemorrhage (>50% of one lateral ventricle)
  • End-stage renal disease
  • End-stage liver disease
  • Presence of mechanical heart valve
  • Platelet count < 75,000/µL
  • INR > 1.4 after correction
  • NIHSS < 5 at admission
  • Bilateral fixed dilated pupils without light reflex
  • Decerebrate posture
  • Ongoing anticoagulation that cannot be rapidly reversed
  • Indication for long-term anticoagulation within 5 days of onset
  • Any comorbidity with life expectancy < 6 months
  • Patient or legal representative unwilling or unable to provide written informed consent

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

This trial is currently available in Vietnam.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This observational cohort study evaluates the safety and effectiveness of minimally invasive surgery (MIS) compared with standard medical management in adults with spontaneous deep intracerebral hemorrhage. Consecutive patients admitted to People's Hospital 115 and Tam Anh General Hospital will be enrolled within 72 hours of onset. Clinical and imaging data will be collected prospectively, and outcomes including survival and functional status will be assessed through 180 days.

The 2 groups in the trial

  • Minimally Invasive Surgery

    Patients with spontaneous deep intracerebral hemorrhage who undergo minimally invasive surgery according to clinical practice.

  • Standard Medical Treatment

    Patients with spontaneous deep intracerebral hemorrhage who receive conventional standard medical care according to clinical practice.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluation Of The Efficacy And Safety Of Minimally Invasive Surgery In Patients With Spontaneous Deep Intracerebral Hemorrhage
Criteria questions
Built from NCT07234955, who can take part
Record updated
19 November 2025